Consolidated Balance Sheets - USD ($)	Dec. 31, 2025	Dec. 31, 2024
Current assets
Cash and cash equivalents	$ 8,705,218	$ 4,164,323
Prepaid expenses and other current assets	1,086,121	1,213,984
Deferred financing costs	99,305	0
Total current assets	9,890,644	5,378,307
Operating lease right-of-use assets	170,733	268,571
Total assets	10,061,377	5,646,878
Current liabilities
Accounts payable	3,435,297	1,284,612
Accrued expenses and other current liabilities	995,290	762,835
Related party payable	116,476	142,459
Operating lease liability, current	145,456	116,323
Debentures	5,245,543	0
Total current liabilities	9,938,062	2,306,229
Loan payable	25,865	0
Operating lease liability, non-current	60,139	205,945
Total liabilities	10,024,066	2,512,174
Commitments and contingencies
Shareholders' equity
Common shares, no par value; 25,176,303 and 11,816,721 shares authorized, issued and outstanding at December 31, 2025 and 2024, respectively	57,076,175	30,518,195
Common shares to be issued	313,934	0
Additional paid-in capital	6,879,575	1,520,412
Accumulated other comprehensive income	10,880	0
Accumulated deficit	(64,348,118)	(28,903,903)
Total shareholders' equity attributable to Medicus Pharma Ltd.	(67,554)	3,134,704
Non-controlling interests	104,865	0
Total shareholders' equity	37,311	3,134,704
Total liabilities and shareholders' equity	$ 10,061,377	$ 5,646,878